Literature DB >> 21245142

Reversible activation of cellular factor XIII by calcium.

Gunhild Klarskov Kristiansen1, Mette Dahl Andersen.   

Abstract

Factor XIII (FXIII) is a pro-transglutaminase found in the plasma as well as intracellularly in platelets and macrophages. Plasma FXIII is activated by thrombin cleavage (FXIIIa*) and acts in the final stages of blood coagulation cascade. In contrast, the function and activation of cellular FXIII are less characterized. Cellular FXIII relies on a conformational activation of the protein. The nonproteolytic activation of FXIII to FXIIIa° induced by Ca(2+) alone is well known, but up until now it has been discussed under which conditions the process can be induced and whether it can be reversed. Here, we study the nature of the Ca(2+)-induced FXIII activation. Previously used methods to evaluate FXIII activity detect both FXIIIa* and FXIIIa° because they rely on occurrence of enzyme activity or on active site Cys-314 solvent accessibility. Therefore, an analytical HPLC method was developed that separates zymogen recombinant FXIII (rFXIII) from rFXIIIa°. The data demonstrate that nonproteolytic activation and deactivation are highly dependent on Ca(2+) concentration, buffer, and salt components. Moreover, it is established that Ca(2+) activation of rFXIII is fully reversible, and only 2-5 mm CaCl(2) is sufficient to retain full rFXIIIa° activity. However, below 2 mm CaCl(2) the rFXIIIa° molecule deactivates. The deactivated molecule can subsequently undergo a new activation round. Furthermore, it is demonstrated that thermal stress of freeze-dried rFXIII can induce a new predisposed form that activates faster than nonstressed rFXIII.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245142      PMCID: PMC3059041          DOI: 10.1074/jbc.M110.174128

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets.

Authors:  L Muszbek; G Haramura; J Polgár
Journal:  Thromb Haemost       Date:  1995-04       Impact factor: 5.249

2.  Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII.

Authors:  V C Yee; L C Pedersen; I Le Trong; P D Bishop; R E Stenkamp; D C Teller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

3.  Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII.

Authors:  V C Yee; L C Pedersen; P D Bishop; R E Stenkamp; D C Teller
Journal:  Thromb Res       Date:  1995-06-01       Impact factor: 3.944

4.  Platelet factor XIII becomes active without the release of activation peptide during platelet activation.

Authors:  L Muszbek; J Polgár; Z Boda
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

5.  The deduced sequence of the novel protransglutaminase E (TGase3) of human and mouse.

Authors:  I G Kim; J J Gorman; S C Park; S I Chung; P M Steinert
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

6.  Interactions of factor XIII with fibrin as substrate and cofactor.

Authors:  T J Hornyak; J A Shafer
Journal:  Biochemistry       Date:  1992-01-21       Impact factor: 3.162

7.  Parathyroid hormone and platelet cytosolic calcium concentration in essential hypertension.

Authors:  E Poch; P Fernández-Llama; A Botey; J Gaya; A Darnell; F Rivera; L Revert
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

8.  Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII).

Authors:  J Polgár; V Hidasi; L Muszbek
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

9.  Inhibitors of the intracellular Ca(2+)-ATPase in cultured mouse keratinocytes reveal components of terminal differentiation that are regulated by distinct intracellular Ca2+ compartments.

Authors:  L Li; R W Tucker; H Hennings; S H Yuspa
Journal:  Cell Growth Differ       Date:  1995-09

10.  Highly active soluble processed forms of the transglutaminase 1 enzyme in epidermal keratinocytes.

Authors:  S Y Kim; S I Chung; P M Steinert
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

View more
  8 in total

1.  Activation of factor XIII is accompanied by a change in oligomerization state.

Authors:  Boris A Anokhin; Vilius Stribinskis; William L Dean; Muriel C Maurer
Journal:  FEBS J       Date:  2017-10-03       Impact factor: 5.542

2.  Role of calcium in the conformational dynamics of factor XIII activation examined by hydrogen-deuterium exchange coupled with MALDI-TOF MS.

Authors:  Ricky T Woofter; Muriel C Maurer
Journal:  Arch Biochem Biophys       Date:  2011-05-26       Impact factor: 4.013

3.  Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.

Authors:  Anna D Protopopova; Andrea Ramirez; Dmitry V Klinov; Rustem I Litvinov; John W Weisel
Journal:  J Thromb Haemost       Date:  2019-03-14       Impact factor: 5.824

Review 4.  Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion.

Authors:  Albe C Swanepoel; Vance G Nielsen; Etheresia Pretorius
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

5.  The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex.

Authors:  Sneha Singh; Alexis Nazabal; Senthilvelrajan Kaniyappan; Jean-Luc Pellequer; Alisa S Wolberg; Diana Imhof; Johannes Oldenburg; Arijit Biswas
Journal:  Biomolecules       Date:  2019-11-21

6.  Characterization of Anopheles gambiae transglutaminase 3 (AgTG3) and its native substrate Plugin.

Authors:  Binh V Le; Jennifer B Nguyen; Shankar Logarajah; Bo Wang; Jacob Marcus; Hazel P Williams; Flaminia Catteruccia; Richard H G Baxter
Journal:  J Biol Chem       Date:  2013-01-03       Impact factor: 5.157

7.  Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective.

Authors:  Sneha Gupta; Arijit Biswas; Mohammad Suhail Akhter; Christoph Krettler; Christoph Reinhart; Johannes Dodt; Andreas Reuter; Helen Philippou; Vytautas Ivaskevicius; Johannes Oldenburg
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

8.  Structure functional insights into calcium binding during the activation of coagulation factor XIII A.

Authors:  Sneha Singh; Johannes Dodt; Peter Volkers; Emma Hethershaw; Helen Philippou; Vytautus Ivaskevicius; Diana Imhof; Johannes Oldenburg; Arijit Biswas
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.